PL1934248T3 - Selektywne peptydowe związki antagonistyczne receptora alfavbeta3 do zastosowań leczniczych i diagnostycznych - Google Patents
Selektywne peptydowe związki antagonistyczne receptora alfavbeta3 do zastosowań leczniczych i diagnostycznychInfo
- Publication number
- PL1934248T3 PL1934248T3 PL06806112T PL06806112T PL1934248T3 PL 1934248 T3 PL1934248 T3 PL 1934248T3 PL 06806112 T PL06806112 T PL 06806112T PL 06806112 T PL06806112 T PL 06806112T PL 1934248 T3 PL1934248 T3 PL 1934248T3
- Authority
- PL
- Poland
- Prior art keywords
- alfavbeta3
- therapeutic
- selective
- diagnostic applications
- peptide antagonist
- Prior art date
Links
- 229940083963 Peptide antagonist Drugs 0.000 title 1
- 102000005962 receptors Human genes 0.000 title 1
- 108020003175 receptors Proteins 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72529405P | 2005-10-12 | 2005-10-12 | |
| EP06806112.6A EP1934248B1 (en) | 2005-10-12 | 2006-10-09 | Selective alfavbeta3 receptor peptide antagonist for therapeutic and diagnostic applications |
| PCT/EP2006/009733 WO2007042241A2 (en) | 2005-10-12 | 2006-10-09 | Selective alfavbeta3 receptor peptide antagonist for therapeutic and diagnostic applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1934248T3 true PL1934248T3 (pl) | 2013-09-30 |
Family
ID=37943159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06806112T PL1934248T3 (pl) | 2005-10-12 | 2006-10-09 | Selektywne peptydowe związki antagonistyczne receptora alfavbeta3 do zastosowań leczniczych i diagnostycznych |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8546526B2 (pl) |
| EP (1) | EP1934248B1 (pl) |
| JP (1) | JP5221355B2 (pl) |
| CA (1) | CA2625436C (pl) |
| ES (1) | ES2413056T3 (pl) |
| PL (1) | PL1934248T3 (pl) |
| WO (1) | WO2007042241A2 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1934248T3 (pl) * | 2005-10-12 | 2013-09-30 | Advanced Accelerator Applications | Selektywne peptydowe związki antagonistyczne receptora alfavbeta3 do zastosowań leczniczych i diagnostycznych |
| US9775803B2 (en) | 2011-10-19 | 2017-10-03 | Samsung Electronics Co., Ltd. | Liposome comprising elastin-like polypeptide and tumor cell targeting material and use thereof |
| MA40998A (fr) | 2014-11-21 | 2017-09-26 | Ophirex Inc | Thérapies contre une envenimation, ainsi que compositions, systèmes et kits pharmaceutiques associés |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19653036A1 (de) * | 1996-12-19 | 1998-06-25 | Merck Patent Gmbh | Cyclopeptidderivate |
| PL1934248T3 (pl) * | 2005-10-12 | 2013-09-30 | Advanced Accelerator Applications | Selektywne peptydowe związki antagonistyczne receptora alfavbeta3 do zastosowań leczniczych i diagnostycznych |
-
2006
- 2006-10-09 PL PL06806112T patent/PL1934248T3/pl unknown
- 2006-10-09 JP JP2008534912A patent/JP5221355B2/ja active Active
- 2006-10-09 US US12/089,709 patent/US8546526B2/en active Active
- 2006-10-09 CA CA2625436A patent/CA2625436C/en active Active
- 2006-10-09 EP EP06806112.6A patent/EP1934248B1/en active Active
- 2006-10-09 WO PCT/EP2006/009733 patent/WO2007042241A2/en not_active Ceased
- 2006-10-09 ES ES06806112T patent/ES2413056T3/es active Active
-
2013
- 2013-08-30 US US14/016,020 patent/US9309288B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2625436A1 (en) | 2007-04-19 |
| US20080213190A1 (en) | 2008-09-04 |
| US9309288B2 (en) | 2016-04-12 |
| CA2625436C (en) | 2016-01-05 |
| EP1934248A2 (en) | 2008-06-25 |
| WO2007042241A3 (en) | 2007-11-29 |
| WO2007042241A2 (en) | 2007-04-19 |
| US20140094412A1 (en) | 2014-04-03 |
| EP1934248B1 (en) | 2013-05-01 |
| US8546526B2 (en) | 2013-10-01 |
| ES2413056T3 (es) | 2013-07-15 |
| JP2009512643A (ja) | 2009-03-26 |
| JP5221355B2 (ja) | 2013-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1951661T3 (pl) | Antagoniści receptora glukagonu, wytwarzanie i terapeutyczne zastosowania | |
| EP2000483A4 (en) | VEGF RECEPTOR FUSION PROTEIN AND APPLICATION THEREOF | |
| EP2058304A4 (en) | P2X4 RECEPTOR ANTAGONIST | |
| IL186527A0 (en) | Toxin peptide therapeutic agents | |
| IL178254A0 (en) | Receptor coupling agents and therapeutic uses thereof | |
| ZA200907094B (en) | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | |
| IL190219A0 (en) | Compounds which have activity at m1 receptor and their uses in medicine | |
| PL2137191T3 (pl) | Antagoniści obwodowego receptora opioidowego i ich zastosowania | |
| SI1951658T1 (sl) | Antagonisti glukagonskega receptorja priprava interapevtska uporaba | |
| IL198650A0 (en) | Progesterone receptor antagonists | |
| IL203898A0 (en) | Cdca1 peptide and pharmaceutical agent comprising the same | |
| HRP20150661T1 (en) | Peripheral opioid receptor and antagonists and uses thereof | |
| PL2420231T3 (pl) | Antagoniści receptora angiotensyny II do leczenia chorób sercowo-naczyniowych u kotów | |
| GB0722996D0 (en) | Depsipeptides and their therapeutic use | |
| GB0524428D0 (en) | Medicinal use of receptor ligands | |
| EP1874800A4 (en) | DIAGNOSTIC AND THERAPEUTIC AGENTS | |
| GB0515140D0 (en) | Therapeutic device | |
| EP1874302A4 (en) | ANTAGONISTS OF ANGIOTENSIN II RECEPTORS | |
| DK1808446T3 (da) | IL-18-receptor-antagonist og farmaceutisk sammensætning indeholdende antagonisten | |
| EP1889565A4 (en) | MEDICAL DEVICE | |
| IL193427A0 (en) | Polypeptide antagonist | |
| GB0526120D0 (en) | Therapeutic peptides | |
| GB0402129D0 (en) | Therapeutic and diagnostic peptides | |
| GB0525029D0 (en) | Receptor Antagonist | |
| EP1951914A4 (en) | DIAGNOSTIC AND THERAPEUTIC METHODS AND AGENTS |